DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20204885

Clinical, haematological, and biochemical profile of HIV patient co-infected with hepatitis B and /or C

Sonu Suman

Abstract


Background: Human immunodeficiency virus (HIV) positive population is at higher risk of getting infected with hepatitis B virus (HBV) or hepatitis C virus (HCV) or both. Co-infection with HBV/HCV may possibly complicate the clinical course of HIV in infected patients. Aim and objectives of the study were intended to determine clinical, haematological and biochemical profile of HIV patients co infected with hepatitis B and/or C.

Methods: All consecutive patients presented with HIV infection who were coinfected with either Hepatitis B, C or both presenting to immunodeficiency or Gastroenterology OPD Base Hospital Delhi, were included in the study. It was a prospective, observational study.

Results: HIV impacts the progression of HCV and increases the likelihood of subsequent liver damage as it is apparent in study by significant raised liver enzymes and hypoalbuminemia in HIV-HCV co infection compare to HIV–HBV.  

Conclusions: These coinfections are more common in younger and lesser educated people. Biochemical parameters could serve as pointers for early detection of liver disease as result of hepatitis co infections in HIV patients. Prompt diagnosis of HCV and HBV co-infection in HIV patients has both individual and public health benefits.


Keywords


Hepatitis B, Hepatitis C, Human immunodeficiency virus, Coinfection of HIV

Full Text:

PDF

References


Barnes E, Webster G, Whalley S, Dusheiko G. Predictors of a favorable response to alpha interferon therapy for hepatitis C. Clini Live Disea. 1999;3(4):775-91.

Murakami J, Shimizu Y, Kashii Y, Kato T, Minemura M, Okada K, et al. Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C. Hepatology, 1999;30:143-50.

Piroth L, Duong M, Quantin C, Abrahamowicz M, Michardiere R, Aho LS, et al. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AID. 1998;12:381-8.

Chung RT. Hepatitis C and B viruses: the new opportunists in HIV infection. Top HIV Med. 2006;14:78-83.

Sulkowski, MS, Thomas, DL. Hepatitis C in the HIV-infected patient. Clin Liv Dis. 2003;7:179-94.

WHO. Hepatitis B fact sheet. Availabll at: http://www.who.int/mediacentre/factsheets/fs204/ en/. Accessed on 10 June 2020.

Perz JF, Farrington LA, Pecoraro C, Hutin YJ, Armstrong GL. Estimated global prevalence of hepatitis C virus infection, Annu. Meet. Infect Dis Soc Am. 957;213.

Dworkin BM, Stahl RE, Giardina MA, Wormser GP, Weiss L, Jankowski R, et al. The liver in acquired immune deficiency syndrome: emphasis on patients with intravenous drug abuse. Am J Gastroenterol. 1987;82:231-6.

Benhamou Y. Antiretroviral therapy and HIV/hepatitis B virus coinfection. Clin Infect Dis. 2004;38(2):S98-103.

Pratt DS, Kaplan MM. Evaluation of liver function. In: Longo 14. Harrison’s principles of internal medicine. New York: Mc Graw Hill. 2012;2527-30

Thio CL, Seaberg EC, Skolasky R, Phair J, Visscher B, Munoz, et al. HIV 1, hepatitis B virus and risk of liver related mortality in the multicenter cohort study (MACS). Lanc. 2002;306:1921-6.

Thio CL. Hepatitis B and human immunodeficiency virus 16. Coinfect Hepatol. 2009;49:S138-45.

Gupta S, Singh S. Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients. Worl J Gastroenterol. 2006;12(42)6879–83.

A. Tremeau-Bravard A, Ogbukagu IC, Ticao CJ, Abubakar JJ. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria. Afric Heal Sci. 2012;12(3):312–7.

Nguyen CH, Ishizaki A, Chung PT, Hoang HT, Nguyen TV, Tanimoto T, et al. Prevalence of HBV infection among different HIV‐risk groups in Hai Phong, Vietnam. J Medic Virol. 2011;83(3):399-404.

Lincoln D, Petoumenos K, Dore GJ, Australian HIV Observational Database. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV medicine. 2003;4(3):241-9.

Lincoln D, Petoumenos K, Dore GJ. Hepatitis B & C virus co-infection in the TREAT. J Gastroenterol Hepatol. 2007;22:1510

Chandra N, Joshi N, Raju YSN, Kumar A, Teja VD. Hepatitis B and/or C co-infection in HIV iAnfected patients: A study in a tertiary care centre from south India. Indian J Med Res. 2013;138:950-4.

Van VT, Hanh NT, Quang NX, Tram LK. Preliminary studies on co-infection of hepatitis B virus, hepatitis C virus in patients with HIV (+) at Bach Mai Hospital. Proceed Scientif Resear Work Bach Mai Hos. 2003;471–8.

Quan VM, Go VF, Nam LV, Bergenstrom A, Thuoc NP, Zenilman J, et al. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case–control study. AID car. 2009;21(1):7-16.

Sereno L, Mesquita F, Kato M, Jacka D, Nguyen TT, Nguyen TN. Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam. J Int Assoc Physici AID Car. 2012;(5):311-20.

Soriano V, Barreiro P, Nunez M. Management of chronic hepatitis B and C in HIV-coinfected patients. J Antimicrob Chemothera. 2006;57(5):815-8.

Pratt DS, Kaplan MM. Evaluation of liver function. In: Longo 14. Harrison’s principles of internal medicine. New York: Mc Graw Hill. 2012;2527-30.

Mgogwe J, Semvua H, Chilongola J. The evolution of haematological and biochemical indices in HIV patients during a six-month treatment period. Afric Heal Sci. 2009;12(1):2-7.

Sulkowski MS. Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors. Clin Infect Dis. 2004.;38(2):90-7.